PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Lanthanum carbonate→

Lanthanum Carbonate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
587-26-8
PubChem CID
168924
Molecular formula
C3La2O9
Molecular weight
457.84 g/mol
Drug class
Lanthanum(III) phosphate-binding agentnon-calcium phosphate binder
Mechanism of action
Dissociates in the gastrointestinal tract and binds dietary phosphate, forming insoluble lanthanum-phosphate complexes that are eliminated in faeces, reducing intestinal phosphate absorption.
Indications / reported uses
  • Control of serum phosphate in patients with chronic kidney disease on dialysis; chewable or oral-powder formulation must be taken with meals according to the product label

Sources: US DailyMed — FOSRENOL (lanthanum carbonate) · NLM MeSH — Lanthanum carbonate · FDA product information

Identification source: PubChem record (CID 168924). The linked PubChem record is provided for identity reference. Confirm the exact salt, hydrate, isomer, mixture, or product form against authoritative source documentation when defining the assessment scope.

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Lanthanum Carbonate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Lanthanum Carbonate Permitted Daily Exposure (PDE) report (the Lanthanum Carbonate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Lanthanum Carbonate Occupational Exposure Limit (OEL) report (the Lanthanum Carbonate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.